Draft Trump order abandons campaign promises to challenge Big Pharma, says consumer advocacy group

The New York Times published  an analysis of a draft Trump executive order on prescription pricing and innovation. US advocacy group consumer rights Public Citizen reviewed portions of the order text in cooperation with the Times.

As a result, Peter Maybarduk, director, Public Citizen’s Access to Medicines Program, issued the following statement.

Big Pharma has captured the Trump administration. The Donald Trump who promised to make medications more affordable, ease Americans’ pain and take on the giant corporations is nowhere to be seen. Instead, the draft Trump executive order, formed in significant part by pharma lobbyist Joe Grogan, would increase profits at the expense of patient safety while failing to reduce costs – and even potentially raising them.